Clinical Trial Update: Study of the Efficacy and Safety of Pegol-Sihematide for Anemia in Patients With NDD-CKD [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial assessing the efficacy and safety of Pegol-Sihematide for anemia in non-dialysis-dependent chronic kidney disease patients is ongoing, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-dialysis Dependent Chronic Kidney Disease

Drugs mentioned

• Pegol-Sihematide (Pegol-Sihematide)

Snippet

Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. | Conditions: Non-Dialysis-Dependent Chronic Kidney Disease | Phase 3 | Status: UNKNOWN